Article Image

IDWeek 2018: What the ID Provider Needs to Know About Novel Immunotherapies

Jay Fishman, MD, FIDSA
Oct 26, 2018
Op-Med is a collection of original essays contributed by Doximity members.
All opinions published on Op-Med are the author’s and do not reflect the official position of Doximity or its editors. Op-Med is a safe space for free expression and diverse perspectives. For more information, or to submit your own opinion, please see our submission guidelines or email opmed@doximity.com.

More from Op-Med

Read Australia Just Made a New Medical Specialty, and the U.S. Should Tooarticle image
Thomas Robitaille, MD Link to Thomas Robitaille, MD's page

Australia Just Made a New Medical Specialty, and the U.S. Should Too

Thomas Robitaille, MD

Jul 23, 2026 Link to Australia Just Made a New Medical Specialty, and the U.S. Should Too

Read Three Lessons I've Learned From My Cancer Patientsarticle image
Ranju Kunwor, MD Link to Ranju Kunwor, MD's page

Three Lessons I've Learned From My Cancer Patients

Ranju Kunwor, MD

Jul 23, 2026 Link to Three Lessons I've Learned From My Cancer Patients

Read Doxing Cost Me My Attending Job. Learn From My Experiencearticle image
David L Wright, MD Link to David L Wright, MD's page

Doxing Cost Me My Attending Job. Learn From My Experience

David L Wright, MD

Jul 23, 2026 Link to Doxing Cost Me My Attending Job. Learn From My Experience